Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
ImmuCell Corporation (ICCC) had Operating Margin of 5.97% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$27.64M |
|
$-1.04M |
|
$16.20M |
|
$11.45M |
|
$25.99M |
|
$1.65M |
|
$-2.68M |
|
$-1.03M |
|
$-1.03M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$1.65M |
|
$4.43M |
|
9.03M |
|
9.03M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$16.94M |
|
$21.07M |
|
$25.59M |
|
$42.53M |
|
$3.98M |
|
$7.49M |
|
$11.50M |
|
$15.48M |
|
$27.06M |
|
$26.96M |
|
$27.06M |
|
9.05M |
|
| Cash Flow Statement Financials | |
$2.48M |
|
$-1.21M |
|
$-1.21M |
|
$3.76M |
|
$3.81M |
|
$0.05M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
0.22 |
|
0.34 |
|
41.40% |
|
|
Operating Margin |
5.97% |
5.97% |
|
16.04% |
|
-3.72% |
|
-3.76% |
|
$1.26M |
|
-- |
|
-- |
|
-- |
|
0.65 |
|
1.75 |
|
8.09 |
|
45.14 |
|
-3.84% |
|
-3.86% |
|
-2.45% |
|
-3.01% |
|
$2.99 |
|
$0.14 |
|
$0.27 |
|